Special Edition: Reduction of Residual Risk in Cardiovascular Disease: Focus on Triglycerides
This special series of Diabetes Core Update is supported by an independent educational grant from Amarin Corp.
For more than 30 years, statins have been the cornerstone of lipid management to reduce the risk of cardiovascular disease (CVD) and heart-related events. These medications have been proven to effectively lower LDL cholesterol levels and CVD risk in a wide array of patient populations. But even after patients meet their LDL cholesterol goals, the risk for CVD-related events isn’t completely abolished—a significant “residual risk” remains in most populations.
In this special two-episode series made possible by an unrestricted educational grant from Amarin Corp, Diabetes Core Update will explore the concept of residual risk in CVD, while specifically discussing the role of triglycerides as a CVD risk factor and a target to reduce residual risk. In each episode, Dr. Neil Skolnik is joined by Dr. Christie Ballantyne (Professor of Medicine-Cardiology and Director of the Center for Cardiometabolic Disease Prevention, Baylor College of Medicine) to discuss the concept of residual risk, how to optimize cardiovascular risk reduction and when to address various factors, the role of high triglycerides in relation to other risk factors, and common clinical cases and real-world challenges to optimally reduce CVD risk in various patient populations.
August 15, 2023
Total Time: 24:43 | File Size: 34.3 MB
In this special episode on Residual Risk: A Focus on Triglycerides, our host, Dr. Neil Skolnik will discuss Residual Risk, Triglycerides and how to reduce residual risk with Dr. Christie Ballantyne, Director of the Center for Cardiometabolic Disease Prevention, Baylor College of Medicine.
This special episode is supported by an independent educational grant from Amarin.
Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Dr. Christie Ballantyne. Dr. Ballantyne is a Professor of Medicine-Cardiology, and Director of the Center for Cardiometabolic Disease Prevention, Baylor College of Medicine.
REFERENCES AND RELATED RESOURCES
Omega-3 Fatty Acids: STRENGTH trial - JAMA. 2020;324(22):2268-2280
Pemafibrate: PROMINENT - N Engl J Med 2022; 387:1923-1934
Icosapent Ethyl: JELIS - Lancet. 2007;369(9567):1090-1098
Icosapent Ethyl: REDUCE-IT - N Engl J Med 2019; 380:11-22
ADA Standards of Care: Diabetes Care 2023;46(Supplement_1):S158–S190
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: Circulation. 2023;148. doi: 10.1161/CIR.0000000000001168
Diabetes Core Update is a monthly audio podcast devoted to presenting and discussing the latest clinically relevant articles from ADA’s four scholarly journals: Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Users can freely access previous episodes of Diabetes Core Update here.